Keyword: Pfizer


Unilever Chief to Quit sooner after failed GSK Bid

27.09.2022 -

British-multinational consumer products giant Unilever has announced that its chief executive, Alan Jope, will retire at the end of 2023. The potentially earlier than...


EMA’s CHMP Greenlights Omicron-1 Vaccines

06.09.2022 -

The human medicines committee (CHMP) of EU drug regulator European Medicines Agency (EMA) has recommended approval of the updated Covid-19 vaccines of Pfizer-BioNTech and...


FDA Grants EUAs to Omicron-targeted Covid Shots

02.09.2022 -

As had been widely expected, the US Food and Drug Administration (FDA) on Aug. 31 granted emergency use authorizations (EUAs) to the new Covid-19 shots developed by mRNA...


Moderna Says Pfizer and BioNTech Infringed Vaccine Patent

30.08.2022 -

BioNTech and Pfizer are facing another lawsuit claiming that their Comirnaty-branded Covid-19 vaccine infringes another company’s patent. The latest to sue is US rival...


Pfizer to Pay $5.4 Billion for Global Blood Therapeutics

09.08.2022 -

Pfizer is paying $5.4 billion to acquire Global Blood Therapeutics (GBT), a drugmaker specialized in treating blood disorders. It is one of several deals the company has...


Pfizer and BioNTech Counter CureVac Lawsuit

03.08.2022 -

Pfizer and BioNTech are fighting back against CureVac’s lawsuit that asserts the makers of the Comirnaty-branded mRNA vaccine for Covid-19 infringed its patent.


GSK’s Consumer Health Flotation Flags

21.07.2022 -

The Jul.18 launch of GSK’s consumer healthcare spinoff Haleon on the London Stock Exchange – said to be the largest London listing in more than a decade – seems to have...


EMA Reviewing Pfizer/BioNTech Covid Shot for Youngest

19.07.2022 -

Pfizer and BioNTech have filed an application with the European Medicines Agency (EMA) for approval of the Comirnaty Covid-19 vaccine in children aged six months to five...